Cannabics Pharmaceuticals

(OTC: CNBX)
Healthcare  |  Biotechnology
0.32 0.01 3.23%
Stock Price | July 19, 2019, 3:56 p.m.
0 Followers
Bid: 0.301
Ask: 0.36
Prev. Close: 0.31
52 Week Low: 0.2548
52 Week High: 1.35
PE Ratio: 24.615385
Dividend Yield: 0.0%

Company Summary

Cannabics Pharmaceuticals Inc is a biotechnology company. It develops pharmaceuticals focusing on cancer research utilizing advanced HTS technology and personalized bioinformatics tools. The company's main focus is the development of therapies and biotechnological tools aimed against diverse ailments and human malignancies. The firm's main product is cannabis oil capsule. Its advanced tools include delivery systems, personalized medicine diagnostics, and therapies based on Cannabinoid compounds.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - Pre-Market Edition 12/27/17

47 Comments
1 year ago

Premium Cannabis Stocks Review - AM Edition 12/26/17

89 Comments
1 year ago

Premium Cannabis Stocks Review - Special Supplement 12/24/17

26 Comments
1 year ago

Premium Cannabis Stocks Review - Special Supplement 12/10/17

47 Comments
1 year ago

Premium Mid-Week Chat

2 years ago

Premium Review of 30 Companies Not on the Focus List

24 Comments
2 years ago